Sure. It's an educated opinion. I'm sure some will quarrel with some assumptions, but you can't dispute the overall message.
Resapp is raising capital at distressed levels if the deal fails, and it'll be hard to make money after incurring such a loss.
What to expect if Pfizer's takeover fails, page-6
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #